77 related articles for article (PubMed ID: 10766170)
1. Nuclear factor-kappaB activation is involved in LMP1-mediated transformation and tumorigenesis of rat-1 fibroblasts.
He Z; Xin B; Yang X; Chan C; Cao L
Cancer Res; 2000 Apr; 60(7):1845-8. PubMed ID: 10766170
[TBL] [Abstract][Full Text] [Related]
2. [Effects of Epstein-Barr virus latent membrane protein 1 mediated by nuclear factor-kappaB on transformation and tumorigenesis of rat-1 cells].
Zhang ZW; He ZM; Zhou M; Zhang Q; Yu YH; Chen ZC
Ai Zheng; 2007 Feb; 26(2):118-22. PubMed ID: 17298737
[TBL] [Abstract][Full Text] [Related]
3. The latent membrane protein 1 (LMP1) encoded by Epstein-Barr virus induces expression of the putative oncogene Bcl-3 through activation of the nuclear factor-kappaB.
Nakamura H; Ishii C; Suehiro M; Iguchi A; Kuroda K; Shimizu K; Shimizu N; Imadome K; Yajima M; Fujiwara S
Virus Res; 2008 Feb; 131(2):170-9. PubMed ID: 17963943
[TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus latent membrane protein 1 CTAR1 mediates rodent and human fibroblast transformation through activation of PI3K.
Mainou BA; Everly DN; Raab-Traub N
Oncogene; 2005 Oct; 24(46):6917-24. PubMed ID: 16007144
[TBL] [Abstract][Full Text] [Related]
5. A novel dominant-negative mutant form of Epstein-Barr virus latent membrane protein-1 (LMP1) selectively and differentially impairs LMP1 and TNF signaling pathways.
Adriaenssens E; Mougel A; Goormachtigh G; Loing E; Fafeur V; Auriault C; Coll J
Oncogene; 2004 Apr; 23(15):2681-93. PubMed ID: 14767477
[TBL] [Abstract][Full Text] [Related]
6. [Construction and function analysis of a CTAR-2 region mutant of the Epstein-Barr virus-encoded latent membrane protein-1].
He ZM; Chen ZC
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Mar; 35(3):261-5. PubMed ID: 12621551
[TBL] [Abstract][Full Text] [Related]
7. BS69 cooperates with TRAF3 in the regulation of Epstein-Barr virus-derived LMP1/CTAR1-induced NF-kappaB activation.
Ikeda O; Miyasaka Y; Yoshida R; Mizushima A; Oritani K; Sekine Y; Kuroda M; Yasui T; Fujimuro M; Muromoto R; Nanbo A; Matsuda T
FEBS Lett; 2010 Mar; 584(5):865-72. PubMed ID: 20138174
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus latent membrane protein-1 (LMP1) C-terminus activation region 2 (CTAR2) maps to the far C-terminus and requires oligomerisation for NF-kappaB activation.
Floettmann JE; Rowe M
Oncogene; 1997 Oct; 15(15):1851-8. PubMed ID: 9362452
[TBL] [Abstract][Full Text] [Related]
9. Transformation of Madin-Darby canine kidney (MDCK) epithelial cells by Epstein-Barr virus latent membrane protein 1 (LMP1) induces expression of Ets1 and invasive growth.
Kim KR; Yoshizaki T; Miyamori H; Hasegawa K; Horikawa T; Furukawa M; Harada S; Seiki M; Sato H
Oncogene; 2000 Mar; 19(14):1764-71. PubMed ID: 10777210
[TBL] [Abstract][Full Text] [Related]
10. Regulation of DNA polymerase beta by the LMP1 oncoprotein of EBV through the nuclear factor-kappaB pathway.
Faumont N; Le Clorennec C; Teira P; Goormachtigh G; Coll J; Canitrot Y; Cazaux C; Hoffmann JS; Brousset P; Delsol G; Feuillard J; Meggetto F
Cancer Res; 2009 Jun; 69(12):5177-85. PubMed ID: 19491276
[TBL] [Abstract][Full Text] [Related]
11. BS69 negatively regulates the canonical NF-kappaB activation induced by Epstein-Barr virus-derived LMP1.
Ikeda O; Sekine Y; Mizushima A; Oritani K; Yasui T; Fujimuro M; Muromoto R; Nanbo A; Matsuda T
FEBS Lett; 2009 May; 583(10):1567-74. PubMed ID: 19379743
[TBL] [Abstract][Full Text] [Related]
12. HSV-tk/GCV gene therapy mediated by EBV-LMP1 for EBV-associated cancer.
Lifang Y; Min T; Midan A; Ya C
J Exp Clin Cancer Res; 2008 Sep; 27(1):42. PubMed ID: 18811956
[TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus latent membrane protein 1 modulates epidermal growth factor receptor promoter activity in a nuclear factor kappa B-dependent manner.
Tao YG; Tan YN; Liu YP; Song X; Zeng L; Gu HH; Tang M; Li W; Yi W; Cao Y
Cell Signal; 2004 Jul; 16(7):781-90. PubMed ID: 15115657
[TBL] [Abstract][Full Text] [Related]
14. Latent membrane protein 1 is critical for efficient growth transformation of human B cells by epstein-barr virus.
Dirmeier U; Neuhierl B; Kilger E; Reisbach G; Sandberg ML; Hammerschmidt W
Cancer Res; 2003 Jun; 63(11):2982-9. PubMed ID: 12782607
[TBL] [Abstract][Full Text] [Related]
15. Immortalized fibroblasts from NF-kappaB RelA knockout mice show phenotypic heterogeneity and maintain increased sensitivity to tumor necrosis factor alpha after transformation by v-Ras.
Gapuzan ME; Schmah O; Pollock AD; Hoffmann A; Gilmore TD
Oncogene; 2005 Sep; 24(43):6574-83. PubMed ID: 16027734
[TBL] [Abstract][Full Text] [Related]
16. Activation of DNA methyltransferase 1 by EBV LMP1 Involves c-Jun NH(2)-terminal kinase signaling.
Tsai CL; Li HP; Lu YJ; Hsueh C; Liang Y; Chen CL; Tsao SW; Tse KP; Yu JS; Chang YS
Cancer Res; 2006 Dec; 66(24):11668-76. PubMed ID: 17178861
[TBL] [Abstract][Full Text] [Related]
17. The transmembrane domains of the EBV-encoded latent membrane protein 1 (LMP1) variant CAO regulate enhanced signalling activity.
Blake SM; Eliopoulos AG; Dawson CW; Young LS
Virology; 2001 Apr; 282(2):278-87. PubMed ID: 11289810
[TBL] [Abstract][Full Text] [Related]
18. Lack of cytotoxic property in a variant of Epstein-Barr virus latent membrane protein-1 isolated from nasopharyngeal carcinoma.
Nitta T; Chiba A; Yamamoto N; Yamaoka S
Cell Signal; 2004 Sep; 16(9):1071-81. PubMed ID: 15212767
[TBL] [Abstract][Full Text] [Related]
19. Electroporation-mediated and EBV LMP1-regulated gene therapy in a syngenic mouse tumor model.
Hsieh YH; Wu CJ; Chow KP; Tsai CL; Chang YS
Cancer Gene Ther; 2003 Aug; 10(8):626-36. PubMed ID: 12872144
[TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr virus latent membrane protein 1 represses p53-mediated DNA repair and transcriptional activity.
Liu MT; Chang YT; Chen SC; Chuang YC; Chen YR; Lin CS; Chen JY
Oncogene; 2005 Apr; 24(16):2635-46. PubMed ID: 15829976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
